After years of losses, London-listed Buccaneer Energy (LON:BUCE) is projected by analysts to turn its first profit in 2026, marking a potential turning point for the US-focused hydrocarbon explorer.
Stephon Dubose has pleaded guilty to the 2023 murder of Angela Risi, a graduate dance student at Duke University, and the attempted murder of her roommate. The attack was motivated by Risi's refusal to commit to an exclusive relationship, prosecutors said.
Rosenblatt Securities raised its rating on cybersecurity firm Fortinet ahead of its Q4 earnings, citing a favorable hardware refresh cycle, effective sales strategies, and supportive tax incentives as key growth drivers.
A sharp $250 billion sell-off across cryptocurrency markets this weekend has been attributed by analysts to a tightening of U.S. dollar liquidity, driven by macro fiscal pressures, rather than a fundamental failure of digital assets.
Morris Chang, the 94-year-old founder of Taiwan Semiconductor Manufacturing Co., made his first public appearance in over a year at a private dinner in Taipei with Nvidia CEO Jensen Huang. The meeting, which ended months of speculation about Chang's health and public role, also served as a platform to reaffirm TSMC's central position in the global chip supply chain.
In a striking departure from her once-fervent loyalty, former Congresswoman Marjorie Taylor Greene has launched a scathing critique of Donald Trump and his MAGA movement, accusing him of abandoning his base for wealthy donors and foreign interests, particularly Israel.
While Arbor Realty Trust offers shareholders clarity on favorable tax treatment for 2025 dividends, analysts remain focused on a deteriorating earnings outlook and a 'Strong Sell' rating, casting doubt on the stock's near-term prospects.
As Pony AI Inc. slashes hardware costs by 70% and plans a major fleet expansion, investors are weighing its potential as a high-stakes bet on the future of self-driving cars in key Asian markets.
Amidst a challenging macro landscape, telecom operator VEON Ltd. is posting robust growth in its core frontier markets while aggressively expanding its digital ecosystem. With a valuation significantly below peers, analysts are debating whether the market is overlooking a hidden gem or rightly pricing in geopolitical risks.
Guggenheim Securities has initiated coverage of clinical-stage biopharma AtaiBeckley with a Buy rating and an $11 price target, highlighting its leadership in next-generation psychiatric treatments following its merger with Beckley Psytech.
Kalshi's parlay betting, newly accessible via Robinhood, generated unprecedented single-day fee revenue last Sunday, surpassing the platform's historical earnings from all non-sports events combined and signaling a major shift in the prediction market landscape.
As Nvidia's historic rally sets a high bar, investors are looking for the next wave of AI winners. Micron Technology and Amazon present compelling cases with unique drivers in the booming ecosystem.
A landmark trade agreement secured during Prime Minister Keir Starmer's visit to Beijing will see Chinese import duties on Scotch whisky cut from 10% to 5%, effective immediately. The move, hailed by industry leaders, is projected to inject £250 million into the UK economy and boost competitiveness in a key growth market.
The new campus in McBee, SC, aims to bolster North American supply chains for critical minerals, starting with a 2,000-ton annual processing capacity for magnet scrap.
Voyager Technologies has commenced a significant expansion of its defense manufacturing facility in Pueblo, Colorado, marking one of the region's largest military-industrial investments in recent years. The project aims to bolster domestic production for missile defense and munitions, integrating advanced automation and AI-driven logistics.
Disney executives detailed a robust start to fiscal 2026, driven by record-breaking animated films, a return to streaming profitability, and major investments in theme parks and AI-powered content. The company signals confidence across its interconnected portfolio.
Synthetic biology leader Twist Bioscience reported strong Q1 FY2026 results, with revenue climbing 17% year-over-year to $103.7 million. Management highlighted accelerating demand from AI-powered drug discovery and reiterated its path to adjusted EBITDA breakeven by Q4 FY2026.
A Barcelona hospital has completed a groundbreaking facial transplant, the first of its kind globally where the donor offered her face as part of an assisted dying process. The recipient, who lost facial function to a severe infection, is now recovering well.
As the U.S. renewable energy sector builds on a record-breaking 2025, it faces a critical juncture defined by supply chain pressures, extreme weather, and evolving market rules. Strategic adaptation, not just growth, will determine its sustainable trajectory.
Twist Bioscience kicks off fiscal 2026 with robust growth, reporting a 17% year-over-year revenue increase to $103.7 million. The company credits its semiconductor-based DNA synthesis platform and surging demand from AI-enabled drug discovery programs as key drivers, while reiterating its path to adjusted EBITDA breakeven within the year.
